Sign up USA
Proactive Investors - Run By Investors For Investors

M Pharmaceutical boss looking forward to a great 2017 and 2018

Gary Thompson is at the helm of drug company M Pharmaceutical, which he describes as a "small company with big ideas".
Talking to Proactive, he said that when finished soon with its acquisition of Cincinnati-based 40 J’s, it will have a current revenue stream from about seven different products, which are FDA cleared.
There are also excitingly two products going through FDA process now - a side-effect-free version of the best-selling slimming product orlistat and a female sexual dysfunction (FSD) remedy.
"I'm looking forward to a great 2017 and 2018," said Thompson.

 
Meet Rainbow Rare Earths Limited, Eurasia Mining plc, Mariana Resources Ltd., Anglo Asian Mining Plc and Hannan Metals Ltd at our event, London, 09 May 2017. Register here »
Giles_55af4ddca6481.jpg
Why Invest In M Pharmaceutical? Read More Here

Register here to be notified of future M Pharmaceutical articles
View full MQ profile

M Pharmaceutical Timeline

Copyright © Proactiveinvestors.com, 2017. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use